title: Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI.
abstract: Contrast agents, such as iron oxide, enhance MR images by altering the relaxation times of tissues in which the agent is present. They can also be used to label targeted molecular imaging probes. Unfortunately, no molecular imaging probe is currently available on the clinical MRI market. A promising platform for MRI contrast agent development is nanotechnology, where superparamagnetic iron oxide nanoparticles (SPIONS) are tailored for MR contrast enhancement, and/or for molecular imaging. SPIONs can be produced using a range of methods and the choice of method will be influenced by the characteristics most important for a particular application. In addition, the ability to attach molecular markers to SPIONS heralds their application in molecular imaging.There are many reviews on SPION synthesis for MRI; however, these tend to be targeted to a chemistry audience. The development of MRI contrast agents attracts experienced researchers from many fields including some researchers with little knowledge of medical imaging or MRI. This situation presents medical radiation practitioners with opportunities for involvement, collaboration or leadership in research depending on their level of commitment and their ability to learn. Medical radiation practitioners already possess a large portion of the understanding, knowledge and skills necessary for involvement in MRI development and molecular imaging. Their expertise in imaging technology, patient care and radiation safety provides them with skills that are directly applicable to research on the development and application of SPIONs and MRI.In this paper we argue that MRI SPIONs, currently limited to major research centres, will have widespread clinical use in the future. We believe that knowledge about this growing area of research provides an opportunity for medical radiation practitioners to enhance their specialised expertise to ensure best practice in a truly multi-disciplinary environment. This review outlines how and why SPIONs can be synthesised and examines their characteristics and limitations in the context of MR imaging.
authors: Division of Medical Radiations, School of Medical Sciences, RMIT University, Victoria, Australia.
authors: J
authors: J
authors: Lodhia
authors: G
authors: G
authors: Mandarano
authors: Nj
authors: Nj
authors: Ferris
authors: P
authors: P
authors: Eu
authors: Sf
authors: S
authors: Cowell
references: Angew Chem Int Ed Engl. 2007;46(8):1222-44
references: 17278160
references: J Phys Chem B. 2005 Mar 10;109(9):3879-85
references: 16851439
references: J Am Chem Soc. 2002 Jul 17;124(28):8204-5
references: 12105897
references: Nanotechnology. 2007 Apr 4;18(13):135103
references: 21730374
references: Exp Neurol. 2004 Jun;187(2):509-16
references: 15144877
references: J Colloid Interface Sci. 1997 Oct 15;194(2):427-33
references: 9398425
references: J Biosci Bioeng. 2005 Jul;100(1):1-11
references: 16233845
references: Nanomedicine (Lond). 2008 Apr;3(2):163-74
references: 18373423
references: J Am Chem Soc. 2005 Apr 27;127(16):5732-3
references: 15839639
references: Science. 1998 Sep 25;281(5385):2013-6
references: 9748157
references: ACS Nano. 2008 May;2(5):847-56
references: 19206481
references: Biomaterials. 2005 Jun;26(18):3995-4021
references: 15626447
references: Nat Mater. 2004 Dec;3(12):891-5
references: 15568032
references: Eur Radiol. 2001;11(11):2319-31
references: 11702180
references: NMR Biomed. 2004 Nov;17(7):484-99
references: 15526347
references: J Am Chem Soc. 2004 Jan 14;126(1):273-9
references: 14709092
references: J Am Chem Soc. 2001 Dec 26;123(51):12798-801
references: 11749537
references: J Biol Inorg Chem. 2004 Sep;9(6):706-12
references: 15232722
references: Langmuir. 2006 Feb 28;22(5):2351-7
references: 16489828
references: J Control Release. 2008 Mar 20;126(3):255-64
references: 18207275
references: Adv Drug Deliv Rev. 2006 Dec 1;58(14):1471-504
references: 17116343
references: Science. 1998 Sep 25;281(5385):2016-8
references: 9748158
references: J Biomed Mater Res A. 2007 Mar 15;80(4):946-54
references: 17083116
references: Eur Biophys J. 1988;15(5):311-9
references: 3366097
references: Nano Lett. 2008 Jun;8(6):1741-5
references: 18489168
references: J Colloid Interface Sci. 1998 Sep 15;205(2):205-212
references: 9735184
references: J Immunol Methods. 1982 Aug 13;52(3):353-67
references: 7130710
references: Bioconjug Chem. 2004 Mar-Apr;15(2):394-401
references: 15025537
references: Chem Rev. 2008 Jun;108(6):2064-110
references: 18543879
references: Magn Reson Med. 1993 Jan;29(1):32-7
references: 7678318
references: Biomaterials. 2004 Oct;25(23):5405-13
references: 15130725
references: Radiology. 2001 May;219(2):316-33
references: 11323453
references: J Colloid Interface Sci. 1999 Apr 15;212(2):474-482
references: 10092379
references: J Am Chem Soc. 2005 Jul 20;127(28):9992-3
references: 16011350
references: J Biomed Biotechnol. 2007;2007:76514
references: 18437227
references: Eur J Pharm Biopharm. 2004 Mar;57(2):369-75
references: 15018998
references: NMR Biomed. 2006 Feb;19(1):142-64
references: 16450332
references: Radiology. 2000 Feb;214(2):568-74
references: 10671613
references: J Magn Reson Imaging. 1999 Feb;9(2):329-35
references: 10077033
references: Nat Med. 2007 Jan;13(1):95-9
references: 17187073
references: Chem Rev. 2005 Apr;105(4):1025-102
references: 15826010
references: Magn Reson Med. 2003 Jul;50(1):201-5
references: 12815696
references: Nat Biotechnol. 2004 Aug;22(8):969-76
references: 15258594
references: Magn Reson Med. 2004 Feb;51(2):273-7
references: 14755651
references: J Am Chem Soc. 2005 Sep 7;127(35):12387-91
references: 16131220
references: Methods Enzymol. 2003;373:175-98
references: 14714404